Schedule 13G ownership disclosure
Whitehawk Therapeutics, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 00032Q104
Event date: 2025-03-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SUVRETTA CAPITAL MANAGEMENT, LLC
Shares: 4,727,510.00 · Class: 9.99%
- Averill Master Fund, Ltd.
Shares: 4,189,490.00 · Class: 8.9%
- Cowen Aaron
Shares: 4,727,510.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-001906
- Form type
- SCHEDULE 13G
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Mar 11, 2025
- Reporting period
- Mar 04, 2025
- Description
- Schedule 13G beneficial ownership